A detailed history of State Street Corp transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, State Street Corp holds 81,918 shares of ATAI stock, worth $126,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81,918
Previous 81,060 1.06%
Holding current value
$126,972
Previous $107,000 11.21%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.16 - $1.64 $995 - $1,407
858 Added 1.06%
81,918 $95,000
Q1 2024

May 15, 2024

SELL
$1.5 - $2.19 $9,027 - $13,179
-6,018 Reduced 6.91%
81,060 $159,000
Q4 2023

Feb 14, 2024

SELL
$1.04 - $1.55 $808,583 - $1.21 Million
-777,484 Reduced 89.93%
87,078 $122,000
Q3 2023

Nov 14, 2023

SELL
$1.27 - $2.28 $17,345 - $31,140
-13,658 Reduced 1.56%
864,562 $1.12 Million
Q2 2023

Aug 14, 2023

BUY
$1.44 - $2.19 $581,271 - $884,017
403,661 Added 85.06%
878,220 $1.51 Million
Q1 2023

May 15, 2023

BUY
$1.17 - $2.7 $29,980 - $69,184
25,624 Added 5.71%
474,559 $858,000
Q4 2022

Feb 14, 2023

BUY
$2.38 - $3.55 $814,212 - $1.21 Million
342,106 Added 320.24%
448,935 $1.19 Million
Q3 2022

Nov 15, 2022

BUY
$3.14 - $4.87 $170,118 - $263,846
54,178 Added 102.9%
106,829 $354,000
Q2 2022

Aug 15, 2022

SELL
$3.03 - $5.32 $43,435 - $76,262
-14,335 Reduced 21.4%
52,651 $192,000
Q1 2022

May 16, 2022

BUY
$4.66 - $7.66 $11,510 - $18,920
2,470 Added 3.83%
66,986 $341,000
Q4 2021

Feb 14, 2022

BUY
$6.82 - $17.8 $439,999 - $1.15 Million
64,516 New
64,516 $492,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $257M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.